1. Home
    /
  2. IPO
Aptus Pharma IPO

22.20x

subscribed

Aptus Pharma IPO

Pharmaceuticals & Drugs
listed
₹2.60LMin. investment
  1. Pre-apply
    22 Sep
  2. Bid start
    23 Sep
  3. Bid end
    25 Sep
  4. Allotment
    26 Sep
  5. Release of funds
    29 Sep
  6. Demat transfer
    29 Sep
  7. Listing
    30 Sep

Aptus Pharma Limited IPO Details

SectorPharmaceuticals & Drugs
Price range₹65.00 – ₹70.00
IPO type
SME
Lot size2000 shares
Issue size₹13Cr
Red Herring Prospectus
Read
Market Cap
₹48.02CrLower than sector avg
RevenueApr 2024 - Mar 2025
₹24.55CrLower than sector avg
Growth rate3Y CAGR
32.95%

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Compare

Companies in this sector
Sun Pharmaceutical Industries LtdSun Pharmaceutical Industries Ltd
Divi's Laboratories LtdDivi's Laboratories Ltd
Torrent Pharmaceuticals LtdTorrent Pharmaceuticals Ltd
Revenue
Higher revenue means strong sales and good market demand
This IPO
₹24.55Cr
This sector
₹1,331.47Cr
Compare with companies
PAT
Higher PAT means strong profitability and efficient cost management
This IPO
₹3.09Cr
This sector
₹193.4Cr
Compare with companies
Market cap
Higher market cap means strong confidence but may suggest overvaluation
This IPO
₹48.02Cr
This sector
₹10,914.84Cr
Compare with companies
P/E ratio
Lower ratio usually means stock is undervalued
This IPO
10.98
This sector
60.87
Compare with companies
D/E ratio
Lower ratio usually means fewer liabilities
This IPO
1.49
This sector
0.43
Compare with companies

Objectives

Working Capital
61.44%
General corporate purposes
26.06%
Capital expenditure
12.52%

About Aptus Pharma Limited

Aptus Pharma is a pharmaceutical marketing and distribution company operating through contract manufacturing with seven manufacturing units. The company offers 194 formulations in 11+ therapeutic segments, such as anti-infectives, cardiovascular, pain relief, anti-diabetic, neuro-psychiatric, and wellness products in various dosage forms. With four divisions and a network of 125+ distributors, it is primarily concentrated mainly in Gujarat (99.2%) and West Bengal (0.8%). Its pan-India distribution is supported by a 17,721 sq. ft. logistics hub in Ahmedabad. In FY25, the company's revenues comprised 94.4% from finished formulations, with anti-infective (29.4%), anti-allergy & respiratory (19.6%), and antacids/gastrointestinal (17.2%) segments.

Aptus Pharma IPO Subscription Status

Date
QIB
NII
Retail
Total
23-Sep-25
0.0 times (X)
4.78 times (X)
1.77 times (X)
1.92 times (X)
24-Sep-25
0.28X
6.11X
5.48X
4.37X
25-Sep-25
1.05X
27.38X
31.28X
22.2X

Frequently asked questions

How to invest in the Aptus Pharma IPO ?

Investors can apply for the Aptus Pharma IPO through their Demat account via the stock exchange or through their broker.

What is the issue size of Aptus Pharma IPO ?

The issue size of the Aptus Pharma IPO is 13 Cr.

What is 'pre-apply' for Aptus Pharma IPO ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Aptus Pharma IPO shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.